Literature DB >> 11753655

PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer.

G Ling1, A Ahmadian, A Persson, A B Undén, G Afink, C Williams, M Uhlén, R Toftgård, J Lundeberg, F Pontén.   

Abstract

It is widely accepted that disruption of the hedgehog-patched pathway is a key event in development of basal cell cancer. In addition to patched gene alterations, p53 gene mutations are also frequent in basal cell cancer. We determined loss of heterozygosity in the patched and p53 loci as well as sequencing the p53 gene in tumors both from sporadic and hereditary cases. A total of 70 microdissected samples from tumor and adjacent skin were subjected to PCR followed by fragment analysis and DNA sequencing. We found allelic loss in the patched locus in 6/8 sporadic basal cell cancer and 17/19 hereditary tumors. All sporadic and 7/20 hereditary tumors showed p53 gene mutations. Loss of heterozygosity in the p53 locus was rare in both groups. The p53 mutations detected in hereditary tumors included rare single nucleotide deletions and unusual double-base substitutions compared to the typical ultraviolet light induced missense mutations found in sporadic tumors. Careful microdissection of individual tumors revealed genetically linked subclones with different p53 and/or patched genotype providing an insight on time sequence of genetic events. The high frequency and co-existence of genetic alterations in the patched and p53 genes suggest that both these genes are important in the development of basal cell cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11753655     DOI: 10.1038/sj.onc.1204946

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Comparison of the expression of p53, p21, Bax and the induction of apoptosis between patients with basal cell carcinoma and normal controls in response to ultraviolet irradiation.

Authors:  M Murphy; M J E M F Mabruk; P Lenane; A Liew; P McCann; A Buckley; C O Flatharta; D Hevey; P Billet; W Robertson; S Javed; M Leader; E Kay; G M Murphy
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

Review 2.  Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics.

Authors:  C A Maschinot; J R Pace; M K Hadden
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

3.  Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation.

Authors:  X Li; W Deng; C D Nail; S K Bailey; M H Kraus; J M Ruppert; S M Lobo-Ruppert
Journal:  Oncogene       Date:  2006-01-26       Impact factor: 9.867

Review 4.  Novel Hedgehog pathway targets against basal cell carcinoma.

Authors:  Jean Y Tang; Po-Lin So; Ervin H Epstein
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-21       Impact factor: 4.219

5.  Loss of Trp53 promotes medulloblastoma development but not skin tumorigenesis in Sufu heterozygous mutant mice.

Authors:  Karin Heby-Henricson; Asa Bergström; Björn Rozell; Rune Toftgård; Stephan Teglund
Journal:  Mol Carcinog       Date:  2011-08-31       Impact factor: 4.784

6.  Repurposing the Clinically Efficacious Antifungal Agent Itraconazole as an Anticancer Chemotherapeutic.

Authors:  Jennifer R Pace; Albert M DeBerardinis; Vibhavari Sail; Silvia K Tacheva-Grigorova; Kelly A Chan; Raymond Tran; Daniel S Raccuia; Robert J Wechsler-Reya; M Kyle Hadden
Journal:  J Med Chem       Date:  2016-04-06       Impact factor: 7.446

7.  Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome.

Authors:  Jean Y Tang; Albert S Chiou; Julian M Mackay-Wiggan; Michelle Aszterbaum; Anita M Chanana; Wayne Lee; Joselyn A Lindgren; Maria Acosta Raphael; Bobbye J Thompson; David R Bickers; Ervin H Epstein
Journal:  Cancer Prev Res (Phila)       Date:  2014-01-17

8.  Formulation and evaluation of itraconazole liposomes for Hedgehog pathway inhibition.

Authors:  Jennifer R Pace; Rajan Jog; Diane J Burgess; M Kyle Hadden
Journal:  J Liposome Res       Date:  2019-10-02       Impact factor: 3.648

Review 9.  [Current diagnostics and therapy recommendations for ocular basal cell carcinoma].

Authors:  V Kakkassery; K U Loeffler; M Sand; K R Koch; A M Lentzsch; A C Nick; I A Adamietz; L M Heindl
Journal:  Ophthalmologe       Date:  2017-03       Impact factor: 1.059

Review 10.  Basal cell carcinomas: attack of the hedgehog.

Authors:  Ervin H Epstein
Journal:  Nat Rev Cancer       Date:  2008-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.